Molecular screening to track ceftriaxone-resistant FC428-like Neisseria gonorrhoeae strains’ dissemination in four provinces of China, 2019 to 2021
BackgroundThe global dissemination of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> FC428-like strains poses a public health concern. To assess and follow their spread, establishing effective antimicrobial resistance (AMR) surveillance systems is essential.AimThis study aimed to track ceftriaxone-resistant FC428-like strains in parts of China, using a molecular screening tool.MethodsSamples were collected from Sichuan, Zhejiang, Shanghai, and Guangdong provinces between 2019 and 2021. We employed a rapid molecular tool - the high-resolution melting analysis-based FC428 (HRM-FC428) assay, to screen for FC428-like strains. All FC428-like strains detected were further characterised by genotyping and PCR-sequencing.ResultsOf 1,042 tested samples, 44 harboured the <i>penA</i>-60.001 allele linked to ceftriaxone resistance, revealing a 4.2% prevalence of FC428-like strains. The HRM-FC428 assay additionally uncovered six strains with mosaic <i>penA</i>-195.001 or <i>penA</i>-232.001 alleles, both bearing the A311V mutation, a ceftriaxone resistance marker. During the study, the prevalence of FC428-like strains among overall samples appeared to increase, with rates of 2.8% (11/395) in 2019, 4.2% (16/378) in 2020, and 6.3% (17/269) in 2021. Some strains' sequence types (ST)s were identified across provinces (e.g. ST1903, ST1600) and most strains (24/44) were ST1903, an ST also reported in other regions/countries, suggesting local evolution and global transmission.ConclusionOur work underscores the value of culture-independent antimicrobial resistance monitoring and validates the use of molecular diagnostic tools, like the HRM-FC428 assay for this purpose. This study offers insights into the complex landscape of ceftriaxone-resistant <i>N. gonorrhoeae</i>, emphasising the importance of continued surveillance and global collaboration to mitigate this growing public health threat.
Authors
- Wenling Cao
- Junping Peng (ORCID: https://orcid.org/0000-0001-7959-5286)
- Leshan Xiu (ORCID: https://orcid.org/0000-0003-0391-1742)
- Jia Huang (ORCID: https://orcid.org/0009-0005-9276-7376)
- Yang Yang (ORCID: https://orcid.org/0000-0002-1290-6665)
- Yamei Li (ORCID: https://orcid.org/0000-0002-1059-7950)
- Youwei Wang (ORCID: https://orcid.org/0009-0005-1505-2887)
- Lihua Hu (ORCID: https://orcid.org/0000-0002-7201-4204)
- Weiming Gu (ORCID: https://orcid.org/0000-0003-0063-7469)
- Liqin Wang
- Gang Yong
Institutions
- Tongji University (CN)
- University of Science and Technology of China (CN)
- University of Electronic Science and Technology of China (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Shandong Provincial Institute of Dermatology and Venereology (CN)
- Guangzhou Institute of Dermatology (CN)
- Shanghai Skin Disease Hospital (CN)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2025-02-13
- DOI
- https://doi.org/10.2807/1560-7917.es.2025.30.6.2400166
- Citations
- 4
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 4.73
Funders
- China Medical Board
- Chinese Academy of Medical Sciences
- Fundamental Research Funds for the Central Universities